Subject: FW: RDV -Georgia_რემდესივირი
From: Maia Nikoleishvili
To: [email-masked]; Mzia GogniashviliMziaakaki abutidzeakakigiorgi chavchavadzegiorgiEkaterine AdamiaEkaterineMarina LatsabidzeMarinaAlisa TsuladzeAlisa
Cc: Beka JakeliBekaTamar GabuniaTamarTinatin KhardzianiTinatin
Date: Wed, 21 Oct 2020 07:58:20 +0000

მოგესალმებით,

გიგზავნით კომპანია „მაილანისგან“ მიღებულ შეთანხმების წერილის პროექტს. შიდსის ცენტრს ვთხოვთ, განიხილონ და დღის ბოლომდე მოგვაწოდონ შენიშვნები/წინადადებები, მწარმოებლის შემდგომი ინფორმირების მიზნით.

აქვე გაცნობებთ, რომ ინდოეთის მხარე ითხოვს 2 ტიპის დოკუმენტს: 1. იმპორტის ლიცენზიას და 2. დასტურს იმის თაობაზე, რომ მედიკამენტის გადაცემა არ მოხდება ადგილობრივი მიმწოდებელი/დისტრიბუტორი კომპანიისთვის (აღნიშნული შინაარსის დოკუმენტი უნდა მომზადდეს შიდსის ცენტრის მიერ).

ჯანდაცვის პოლიტიკის სამმართველოს ვთხოვთ, იმპორტის ლიცენზიასთან დაკავშირებული საკითხის გარკვევას.

დანართის სახით კიდევ ერთხელ გიგზავნით კომპანია „მაილანის“ მიერ წარმოებულ რემდესივირთან დაკავშირებულ დოკუმენტაციას.

პატივისცემით,

მაია ნიკოლეიშვილი

ადმინისტრაციის საერთაშორისო ურთიერთობებისა და პროტოკოლის სამმართველოს უფროსი

საქართველოს ოკუპირებული ტერიტორიებიდან დევნილთა, შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო

მის: წერეთლის გამზ. 144 თბილისი 0159 საქართველო

ტელ.: +995 32 2510034 (0803)

მობ.: +995 577 272713

ელ. ფოსტა: [email-masked]

From: Abhishek Datta
Sent: Wednesday, October 21, 2020 9:16 AM
To: Maia Nikoleishvili [email-masked]>
Cc: Suresh Karavadi
Subject: RDV - Georgia

Dear Maia

As discussed, please find attached draft copy of agreement.

We need 2 inputs from your side:

Import License for Georgia

Confirmation that the stocks will not be supplied to any Wholesaler/Distributor locally

Please do let us know if you have any questions. Mr. Suresh marked in CC is from our legal team, he will help in case you need any clarity from legal point of view.

Warm Regards,

Abhishek

This email message and any attachments are for the exclusive use of the intended addressee(s). This message may contain confidential, privileged and/or proprietary information, and unauthorized review, use or distribution by persons other than the intended addressee(s) is strictly prohibited and may be unlawful. Unintended transmission does not waive any privilege including attorney-client, attorney work product or claims to confidentiality. If you received this email in error or it was forwarded from recipients who received it in error, please contact me by return message and immediately destroy all electronic, paper and other versions of this message. Thank you.

Please think before you print.

View in other languages.

From: Maia Nikoleishvili
Sent: Tuesday, October 20, 2020 3:13 PM
To: Jaspal Singh Virk
Cc: 'Abhishek Datta' ; Elena Magura ; Prashant Deshpande ; Harpal Singh ; Tamar Gabunia ; [email-masked]; Ekaterine Adamia ; Tinatin Khardziani ; Beka Jakeli ; [email-masked]; akaki abutidze ; Sudhir Desai
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

Dear Jaspal,

We are looking forward to receiving the first draft of the contract for internal revision.

If there is any other provisions to be added from you side, you can include later.

Ambassador of Georgia to India informed us that the Charter flight might be arranged on 29th of October, therefore, it’s highly important to complete all internal procedures related to the delivery ASAP. We hope as well that the export license will be obtained before the end of this week.

Please, kindly send the draft contract as early as possible.

Thank you in advance.

Best regards,

Maia

From: Abhishek Datta <[email-masked]>
Sent: Friday, October 16, 2020 2:52 PM
To: Maia Nikoleishvili <[email-masked]>; Jaspal Singh Virk <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]; Ekaterine Adamia <[email-masked]>; Tinatin Khardziani <[email-masked]>; Beka Jakeli <[email-masked]>; [email-masked]; akaki abutidze <[email-masked]>; Sudhir Desai <[email-masked]>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High

Dear Maia

We confirm the receipt of PO. As discussed, we will apply for export license immediately.

As for agreement we have shared the details with our legal team. They will share the draft shortly.

Dear Jaspal

As discussed, can you please apply for export license immediately. Ms. Maia said if you can share the details of concerned person/team who issue export license they can try from their side for faster approval.

So, kindly share the details with them.

Also, we need to plan for dispatch as soon as we get export license.

Warm Regards,

Abhishek

From: Maia Nikoleishvili <[email-masked]>
Sent: Friday, October 16, 2020 3:08 PM
To: Abhishek Datta <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]; Ekaterine Adamia <[email-masked]>; Tinatin Khardziani <[email-masked]>; Beka Jakeli <[email-masked]>; [email-masked]; akaki abutidze <[email-masked]>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.

Dear Abhishek,

Please, find the enclosed PO for 4000 vial Remdesivir signed by the Infectious Diseases, AIDS and Clinical Immunology Research Center.

Considering current epidemiological situation, we kindly request you to rapidly finalize formal procedures necessary for obtaining export license and consequently, to deliver the goods as early as possible.

Meanwhile, please share your draft contract and we will provide our suggestions and comments.

Thank you once again for your efforts and continued support.

Best regards,

Maia

From: Abhishek Datta <[email-masked]>
Sent: Thursday, October 15, 2020 5:03 PM
To: Maia Nikoleishvili <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]; Ekaterine Adamia <[email-masked]>; Tinatin Khardziani <[email-masked]>; Beka Jakeli <[email-masked]>; [email-masked]; akaki abutidze <[email-masked]>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

Dear Maia

Please share us the PO for 4K as mentioned below.

The PO additional quantity will be only used for applying Export License & there will be no obligation to purchase full quantity.

Warm Regards,

Abhishek

From: Maia Nikoleishvili <[email-masked]>
Sent: Thursday, October 15, 2020 6:05 PM
To: Abhishek Datta <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]; Ekaterine Adamia <[email-masked]>; Tinatin Khardziani <[email-masked]>; Beka Jakeli <[email-masked]>; [email-masked]; akaki abutidze <[email-masked]>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.

Dear Abhishek,

Hope you are doing well.

Please, be kindly informed that the Ministry is going to procurer initially 4000 vials of Remdesivir 100 mg through Infectious Diseases, AIDS and Clinical Immunology Research Center, which is a state-owned hospital. Therefore, the PO will be sent on behalf of the AIDS Center.

In addition, kindly request you to confirm that by indicating increased amount of Remdesivir in the PO, it will not impose an obligation to purchase full quantity. As I understand, this procedure is necessary only for submission to the export license and in case of additional order we will avoid to go through this procedure again.

Looking forward to receiving you feedback.

Best regards,

Maia

From: Abhishek Datta <[email-masked]>
Sent: Tuesday, October 13, 2020 6:33 PM
To: Maia Nikoleishvili <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

Hi Maia

Please find attached 2 sets of Carton, Label & PIL from our 2-manufacturing facility

Warm Regards,

Abhishek

From: Abhishek Datta
Sent: Tuesday, October 13, 2020 7:35 PM
To: Maia Nikoleishvili <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

Dear Maria

As discussed, please find attached WHO GMP, CoA & COC & Free Sales Certificate.

Do let us know if you need any other documents.

Warm Regards,

Abhishek

From: Abhishek Datta
Sent: Tuesday, October 13, 2020 3:07 PM
To: Maia Nikoleishvili <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High

Dear Ms. Maria

It was good to connect with you!

As discussed, we need to apply for Export License before we make any commercial supplies. For applying Export license, we need a dummy Purchase Order on your letter head may be with some extra quantity like 100,000 vials. We will use this purchase order only for applying export license not for commercial supplies.

Mylan has license from Gilead to supply to Georgia. The final price offer would be USD 26.00/vial (CIP Tbilisi)

We agree with the payment terms.

Please share us the list of documents you need from our side.

Warm Regards,

Abhishek

From: Maia Nikoleishvili <[email-masked]>
Sent: Tuesday, October 13, 2020 12:51 PM
To: Abhishek Datta <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan

CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.

Dear Mr. Abhishek,

Many thanks for your prompt reply.

As we agreed over the phone, please kindly review the price and offer discount, the lowest possible price.

Please, also clarify the terms of delivery and inform us procedure necessary for immediate dispatching the goods.

As for the payment terms, please note that since we are governmental organization, it would be difficult for us to pay the total value of goods in advance. Therefore, kindly request you to consider payment after delivery or 20 percent in advance and 80 percent after receiving the goods.

And also send me all documentation related to the medication.

Thank you once again for your readiness to support Georgia and I believe that this cooperation will be beneficial for both of our sides.

Best regards,

Maia

+995 577272713 (WhatsApp number)

From: Abhishek Datta <[email-masked]>
Sent: Tuesday, October 13, 2020 9:10 AM
To: Maia Nikoleishvili <[email-masked]>
Cc: Elena Magura <[email-masked]>; Prashant Deshpande <[email-masked]>; Harpal Singh <[email-masked]>; Tamar Gabunia <[email-masked]>; [email-masked]
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High

Dear Maria

Greetings from Mylan!

Thanks for sharing your requirements for Remdesivir.

We would be glad to offer 3000 Vials for 500 patients (i.e. 6 vials/patients). The delivery timelines would be 2-3 weeks (depending of receipt of Export License for Georgia).

The offer price would be USD 28.00/vial (Incoterms: CIF Tbilisi).

Please do let us know if you need any other information or documents from our side. My contact details are shared in my below signature.

Looking forward to hearing from you!

Warm Regards

Abhishek Datta

Business Development

Mylan Laboratories Limited

Hyderabad, India

Direct +91 40 3086 6265

Mobile +91 8008553783

From: Maia Nikoleishvili <[email-masked]>
Sent: Saturday, October 10, 2020 3:38 PM
To: Mylan Customer Service <[email-masked]>; Communications India and EM <[email-masked]>
Cc: Tamar Gabunia <[email-masked]>; Archil Dzuliashvili <[email-masked]>
Subject: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High

CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.

Dear Sirs,

I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by Mylan under a license from Gilead Science Inc.

Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.

Therefore, we urgently need to procurer  Remdesivir, initially sufficient for 500 eligible patients and kindly request you to provide us with the product price as well as terms and conditions of delivery as early as possible.

We rely on your support and do hope that our cooperation will be fruitful and successful.

Looking forward to receiving your feedback as soon as possible.

Sincerely yours,

Maia Nikoleishvili MPA

Head of International Relations and Protocol Division

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: [email-masked]

This email message and any attachments are for the exclusive use of the intended addressee(s). This message may contain confidential, privileged and/or proprietary information, and unauthorized review, use or distribution by persons other than the intended addressee(s) is strictly prohibited and may be unlawful. Unintended transmission does not waive any privilege including attorney-client, attorney work product or claims to confidentiality. If you received this email in error or it was forwarded from recipients who received it in error, please contact me by return message and immediately destroy all electronic, paper and other versions of this message. Thank you.

Please think before you print.

View in other languages.